
- Volume 0 0
Methotrexate for Injection USP
Bedford Laboratories (Bedford, Ohio), a division of Ben Venue Laboratories Inc, recently added Methotrexate for Injection USP, 1 g, to its line of oncology products. Methotrexate for Injection USP is indicated for the treatment of certain neoplastic diseases, severe psoriasis, and adult rheumatoid arthritis. The product is supplied in 4 singledose, preservative-free liquid presentations, containing 25 mg/mL of methotrexate sodium?50 mg in 2 mL, 100 mg in 4 mL, 200 mg in 8 mL, 250 mg in 10 mL?and in a 1- g single-dose, preservative-free lyophilized powder. For more information, visit www.bedfordlabs.com, or call 800-521-5169.
Articles in this issue
about 20 years ago
CAN YOU READ THESE Rxs?about 20 years ago
Bar Coding Thwarts Illegitimate Drug Useabout 20 years ago
Hypertension Counseling Requires a Multifactorial Approachabout 20 years ago
COMPOUNDING HOTLINEabout 20 years ago
Pharmacy Law: Duty to Warn Waived When Patient Refuses Counselingabout 20 years ago
EnterpriseRx Pharmacy Management Systemabout 20 years ago
Hospital Installs Automated Medication Cabinetsabout 20 years ago
"Smartphones" Help with Clinical Trial Informationabout 20 years ago
HIT Needs Medicare's LeadershipNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

















































































































































































































